AngioDynamics, Inc. (ANGO) Tops Q1 EPS by 1c; Lowers FY13 EPS outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Analysts Sees Synergies and Struggles in AngioDynamics' (ANGO) Latest Acquisition
October 9, 2012 10:41 AM EDTAngioDynamics (NASDAQ: ANGO) recently reported first quarter earnings, with revenue in line with guidance. ANGO also announced the acquisition of Vortex Medical.
"On the plus side, we see potentially positive synergies with ANGO's existing PV line. That said, the purchase price... More
